Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Capuz Diaz Edwin Santiago"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • No Thumbnail Available
    Item
    SECUELAS EN PACIENTES POST INFECCIÓN POR COVID 19, UN COMPARATIVO ANTES Y DESPUÉS DE LA VACUNACIÓN
    (2025-06-16) Capuz Diaz Edwin Santiago; Romo López Ángel Geovanny; Universidad Técnica de Ambato / Facultad de Ciencias de Salud / Carrera de Medicina
    The coronavirus outbreak in 2019, reported in the city of Wuhan, Hubei province in China, caused by a type-2 severe acute respiratory syndrome virus, leading to a global declaration as a pandemic in 2020, a fatality rate of 1% to 3% of the population affected, mainly older adults, is estimated worldwide, adding those people who had some type of comorbidity such as Diabetes, High blood pressure, cardiovascular disease and some type of disease. of Cancer. On February 29, 2020, the Ministry of Public Health of Ecuador confirmed the first case of COVID 19 in the city of Guayaquil, however this would only be the beginning of an unimaginable outbreak of infections in said city and at the country level, had a great global impact since until August 28, 2022 we had a report of 598 million confirmed cases and a total of 6.4 million deaths globally. Causes acute respiratory syndrome in the initial stages, but over time the presence of digestive, renal, hepatic, cardiovascular and neurological disorders has been observed in different stages, whether acute, subacute and chronic. In 2021, tests and studies were already being carried out for the viability of immunization at a global level, but this did not guarantee 100% immunity since 60% of people could be infected again given the characteristics of the mutation.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify